Also trades as: 3L7A.F (FSX) · $vol 0M
QLYS NASDAQ
Qualys, Inc.
1W: +19.6%
1M: +31.1%
3M: +68.7%
YTD: +74.0%
1Y: +78.0%
3Y: +46.3%
5Y: +98.3%
$227.90
+2.75 (+1.22%)
Weekly Expected Move ±7.2%
$185
$201
$217
$232
$248
Credit Risk of going bust: lower than 80% of companies Debt: 0.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 99.9%), Qualys, Inc. would be worth roughly what it owes.
Total debt $53.4M against a stock market value of $7.88B.
Distance to default 9.77 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $26.7M (short-term plus half of long-term), stock volatility 57.2%; Altman Z'' 3.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.19 (down 99.9%), Qualys, Inc. would be worth roughly what it owes.
Total debt $53.4M against a stock market value of $7.88B.
Distance to default 9.77 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $26.7M (short-term plus half of long-term), stock volatility 57.2%; Altman Z'' 3.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$704M
Revenue
+10.5% YoY
$207M
Net Income
+11.6% YoY
$314M
Free Cash Flow
+31.1% YoY
83.4%
Gross Margin
34.0%
Op. Margin
28.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE38.6%
ROA19.9%
ROIC101.5%
Valuation
P/E39.3
P/B14.3
EV/EBITDA16.4
Leverage
Debt/Equity0.09
Current Ratio1.38
Interest Cov.0.0x
Quality Scores
Piotroski F9/9
Altman Z7.10
Beneish M-2.91